2002
DOI: 10.1016/s0920-9964(01)00180-3
|View full text |Cite
|
Sign up to set email alerts
|

Color discrimination in schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
29
3
3

Year Published

2007
2007
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(40 citation statements)
references
References 29 publications
5
29
3
3
Order By: Relevance
“…In the isoluminant blue-onyellow and high contrast achromatic conditions, there were no significant differences between the groups. This in contrast to Shuwairi et al (2002) who found general hue discrimination errors evaluated by five color discrimination measurements, in patients with schizophrenia, and also to evidence showing that other neuropsychiatric conditions that involve dopaminergic depletion (like PD and patients with cocaine withdrawal) were associated with color discrimination deficits along the blue-hue (tritan-wavelength-sensitive) axis. No significant differences were found between the three groups regarding luminance contrast threshold for achromatic dots.…”
Section: Vernier Acuitycontrasting
confidence: 55%
See 3 more Smart Citations
“…In the isoluminant blue-onyellow and high contrast achromatic conditions, there were no significant differences between the groups. This in contrast to Shuwairi et al (2002) who found general hue discrimination errors evaluated by five color discrimination measurements, in patients with schizophrenia, and also to evidence showing that other neuropsychiatric conditions that involve dopaminergic depletion (like PD and patients with cocaine withdrawal) were associated with color discrimination deficits along the blue-hue (tritan-wavelength-sensitive) axis. No significant differences were found between the three groups regarding luminance contrast threshold for achromatic dots.…”
Section: Vernier Acuitycontrasting
confidence: 55%
“…Nevertheless, the results are consistent with Regan and Maxner (1987) and other authors' findings in PD, regarding the effect of impairment of the visual pathway leading from the retina to the occipital cortex via the magnocellular layer of the lateral geniculate body (rather than the parvocellular pathway) on visual processing dysfunctions, although the type of DA functioning impairment is different in this disease. However, the lack of DA medication might perhaps be related to the lack of effect on the isoluminant blue-on-yellow condition, since previous studies (Shuwairi et al, 2002) found a general hue discrimination deficits in medicated patients.…”
Section: Vernier Acuitymentioning
confidence: 96%
See 2 more Smart Citations
“…In fact, a reduced P3 amplitude is one of the most robust ERP findings concerning schizophrenia (Jeon and Polich, 2003) and may reflect a reduced allocation of attentional resources. However, as the features of the P3 are mainly modality nonspecific, this effect does not point to an altered color perception, which seems to be normal in schizophrenia patients (Kopala et al, 1995;Shuwariri et al, 2002). Moreover, a reduced P3 amplitude is not disorderspecific, but is a robust finding also present in other disorders (e.g.…”
Section: Discussionmentioning
confidence: 87%